FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4242362430> ?p ?o ?g. }

• W4242362430 endingPage "S752" @default.
• W4242362430 startingPage "S752" @default.
• W4242362430 abstract "Purpose/Objective(s)This study prospectively investigated Protoporphyrin (PpIX) fluorescence as a means of determining the clinical target volume (CTV) necessary to encompass subclinical disease for non-melanotic skin cancers.Materials/MethodsPpIX photo-delineation was performed on 30 patients by applying δ-aminolevulinic acid (ALA) or Metvix™ (MAL) cream to the lesions to be treated, in order to delineate a CTV prior to treatment with radiation therapy. This CTV was then compared to conventional margins for subclinical disease (10 mm for poorly demarcated tumors).ResultsOf the 30 patients sampled, 26 (87%) of the lesions were BCCs and 4 (13%) were SCCs. 16/30 (53%) patients had primary nasal tumors. Seven (23%) patients had well-demarcated lesions and 23 (77%) patients had poorly demarcated tumors. The PpIX photo-delineation demonstrated a significant larger CTV - of 15 mm versus the conventional 10 mm expansion - for 16/23 (70%) cases of poorly demarcated lesions (p = 0.008), as well as for all BCCs (mean CTV with PpIX photo-delineation = 13 mm, p = 0.03) and for non-nasal lesions (mean CTV = 14 mm, p = 0.03). Nasal lesions had multifocal PpIX uptake in 15 of 16 cases (94%): the average expansion from PpIX fluorescence was 14 mm (variance = 122.9, p = 0.13), though this was not statistically significant. The local control rate after radiation therapy was 95.6% at 17.7 months.ConclusionsPpIX photo-delineation suggests that conventional 10 mm margins may be inadequately covering areas of subclinical disease in poorly demarcated skin tumors. PpIX photo-delineation also showed nasal lesions to be multifocal. Longer follow-up may be necessary to determine if this increase in CTV is clinically significant. Purpose/Objective(s)This study prospectively investigated Protoporphyrin (PpIX) fluorescence as a means of determining the clinical target volume (CTV) necessary to encompass subclinical disease for non-melanotic skin cancers. This study prospectively investigated Protoporphyrin (PpIX) fluorescence as a means of determining the clinical target volume (CTV) necessary to encompass subclinical disease for non-melanotic skin cancers. Materials/MethodsPpIX photo-delineation was performed on 30 patients by applying δ-aminolevulinic acid (ALA) or Metvix™ (MAL) cream to the lesions to be treated, in order to delineate a CTV prior to treatment with radiation therapy. This CTV was then compared to conventional margins for subclinical disease (10 mm for poorly demarcated tumors). PpIX photo-delineation was performed on 30 patients by applying δ-aminolevulinic acid (ALA) or Metvix™ (MAL) cream to the lesions to be treated, in order to delineate a CTV prior to treatment with radiation therapy. This CTV was then compared to conventional margins for subclinical disease (10 mm for poorly demarcated tumors). ResultsOf the 30 patients sampled, 26 (87%) of the lesions were BCCs and 4 (13%) were SCCs. 16/30 (53%) patients had primary nasal tumors. Seven (23%) patients had well-demarcated lesions and 23 (77%) patients had poorly demarcated tumors. The PpIX photo-delineation demonstrated a significant larger CTV - of 15 mm versus the conventional 10 mm expansion - for 16/23 (70%) cases of poorly demarcated lesions (p = 0.008), as well as for all BCCs (mean CTV with PpIX photo-delineation = 13 mm, p = 0.03) and for non-nasal lesions (mean CTV = 14 mm, p = 0.03). Nasal lesions had multifocal PpIX uptake in 15 of 16 cases (94%): the average expansion from PpIX fluorescence was 14 mm (variance = 122.9, p = 0.13), though this was not statistically significant. The local control rate after radiation therapy was 95.6% at 17.7 months. Of the 30 patients sampled, 26 (87%) of the lesions were BCCs and 4 (13%) were SCCs. 16/30 (53%) patients had primary nasal tumors. Seven (23%) patients had well-demarcated lesions and 23 (77%) patients had poorly demarcated tumors. The PpIX photo-delineation demonstrated a significant larger CTV - of 15 mm versus the conventional 10 mm expansion - for 16/23 (70%) cases of poorly demarcated lesions (p = 0.008), as well as for all BCCs (mean CTV with PpIX photo-delineation = 13 mm, p = 0.03) and for non-nasal lesions (mean CTV = 14 mm, p = 0.03). Nasal lesions had multifocal PpIX uptake in 15 of 16 cases (94%): the average expansion from PpIX fluorescence was 14 mm (variance = 122.9, p = 0.13), though this was not statistically significant. The local control rate after radiation therapy was 95.6% at 17.7 months. ConclusionsPpIX photo-delineation suggests that conventional 10 mm margins may be inadequately covering areas of subclinical disease in poorly demarcated skin tumors. PpIX photo-delineation also showed nasal lesions to be multifocal. Longer follow-up may be necessary to determine if this increase in CTV is clinically significant. PpIX photo-delineation suggests that conventional 10 mm margins may be inadequately covering areas of subclinical disease in poorly demarcated skin tumors. PpIX photo-delineation also showed nasal lesions to be multifocal. Longer follow-up may be necessary to determine if this increase in CTV is clinically significant." @default.
• W4242362430 created "2022-05-12" @default.
• W4242362430 creator A5000695802 @default.
• W4242362430 creator A5006381627 @default.
• W4242362430 creator A5020153753 @default.
• W4242362430 creator A5026926669 @default.
• W4242362430 creator A5050801513 @default.
• W4242362430 creator A5051407430 @default.
• W4242362430 creator A5065290565 @default.
• W4242362430 creator A5065708016 @default.
• W4242362430 creator A5079363575 @default.
• W4242362430 date "2014-09-01" @default.
• W4242362430 modified "2023-10-12" @default.
• W4242362430 title "Use of Protoporphyrin Fluorescence to Determine Clinical Target Volumes for Nonmelanotic Skin Cancers Treated With Primary Radiation Therapy" @default.
• W4242362430 doi "https://doi.org/10.1016/j.ijrobp.2014.05.2184" @default.
• W4242362430 hasPublicationYear "2014" @default.
• W4242362430 type Work @default.
• W4242362430 citedByCount "0" @default.
• W4242362430 crossrefType "journal-article" @default.
• W4242362430 hasAuthorship W4242362430A5000695802 @default.
• W4242362430 hasAuthorship W4242362430A5006381627 @default.
• W4242362430 hasAuthorship W4242362430A5020153753 @default.
• W4242362430 hasAuthorship W4242362430A5026926669 @default.
• W4242362430 hasAuthorship W4242362430A5050801513 @default.
• W4242362430 hasAuthorship W4242362430A5051407430 @default.
• W4242362430 hasAuthorship W4242362430A5065290565 @default.
• W4242362430 hasAuthorship W4242362430A5065708016 @default.
• W4242362430 hasAuthorship W4242362430A5079363575 @default.
• W4242362430 hasBestOaLocation W42423624301 @default.
• W4242362430 hasConcept C113280763 @default.
• W4242362430 hasConcept C121608353 @default.
• W4242362430 hasConcept C126322002 @default.
• W4242362430 hasConcept C126838900 @default.
• W4242362430 hasConcept C142724271 @default.
• W4242362430 hasConcept C146357865 @default.
• W4242362430 hasConcept C151730666 @default.
• W4242362430 hasConcept C178790620 @default.
• W4242362430 hasConcept C185592680 @default.
• W4242362430 hasConcept C2777789703 @default.
• W4242362430 hasConcept C2779671804 @default.
• W4242362430 hasConcept C2781323092 @default.
• W4242362430 hasConcept C2989005 @default.
• W4242362430 hasConcept C509974204 @default.
• W4242362430 hasConcept C71924100 @default.
• W4242362430 hasConcept C86803240 @default.
• W4242362430 hasConceptScore W4242362430C113280763 @default.
• W4242362430 hasConceptScore W4242362430C121608353 @default.
• W4242362430 hasConceptScore W4242362430C126322002 @default.
• W4242362430 hasConceptScore W4242362430C126838900 @default.
• W4242362430 hasConceptScore W4242362430C142724271 @default.
• W4242362430 hasConceptScore W4242362430C146357865 @default.
• W4242362430 hasConceptScore W4242362430C151730666 @default.
• W4242362430 hasConceptScore W4242362430C178790620 @default.
• W4242362430 hasConceptScore W4242362430C185592680 @default.
• W4242362430 hasConceptScore W4242362430C2777789703 @default.
• W4242362430 hasConceptScore W4242362430C2779671804 @default.
• W4242362430 hasConceptScore W4242362430C2781323092 @default.
• W4242362430 hasConceptScore W4242362430C2989005 @default.
• W4242362430 hasConceptScore W4242362430C509974204 @default.
• W4242362430 hasConceptScore W4242362430C71924100 @default.
• W4242362430 hasConceptScore W4242362430C86803240 @default.
• W4242362430 hasIssue "1" @default.
• W4242362430 hasLocation W42423624301 @default.
• W4242362430 hasOpenAccess W4242362430 @default.
• W4242362430 hasPrimaryLocation W42423624301 @default.
• W4242362430 hasRelatedWork W1951626490 @default.
• W4242362430 hasRelatedWork W1997012417 @default.
• W4242362430 hasRelatedWork W2010818431 @default.
• W4242362430 hasRelatedWork W2011743583 @default.
• W4242362430 hasRelatedWork W2044790523 @default.
• W4242362430 hasRelatedWork W2187275941 @default.
• W4242362430 hasRelatedWork W2514227379 @default.
• W4242362430 hasRelatedWork W2516171632 @default.
• W4242362430 hasRelatedWork W2954825697 @default.
• W4242362430 hasRelatedWork W929688625 @default.
• W4242362430 hasVolume "90" @default.
• W4242362430 isParatext "false" @default.
• W4242362430 isRetracted "false" @default.
• W4242362430 workType "article" @default.